StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)

Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%

TransMedics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

TransMedics's pe ratio was 23.9× on Nov 11, 2026, against 59.2× a year earlier. Over the last 2 years it ranged from 15.2× to 98.5×, with a median of 58.1×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202623.9×−25.4
2025Dec 31, 202549.3×−17.1
2024Dec 31, 202466.3×–

More TransMedics figures

See a number that looks wrong?